Rea, D., Gray, R., Bowden, S., Handley, K., Earl, H., Poole, C., . . . Lee, M. (2013). Overall and subgroup findings of the aTTom trial: A randomised comparison of continuing adjuvant tamoxifen to 10 years compared to stopping after 5 years in 6953 women with ER positive or ER untested early breast cancer.
Cytowanie według stylu Chicago (wyd. 17)Rea, D., et al. Overall and Subgroup Findings of the ATTom Trial: A Randomised Comparison of Continuing Adjuvant Tamoxifen to 10 Years Compared to Stopping After 5 Years in 6953 Women with ER Positive or ER Untested Early Breast Cancer. 2013.
Cytowanie według stylu MLA (wyd. 9)Rea, D., et al. Overall and Subgroup Findings of the ATTom Trial: A Randomised Comparison of Continuing Adjuvant Tamoxifen to 10 Years Compared to Stopping After 5 Years in 6953 Women with ER Positive or ER Untested Early Breast Cancer. 2013.